These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 23267129)

  • 1. Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells.
    Li QQ; Lee RX; Liang H; Zhong Y
    Anticancer Res; 2013 Jan; 33(1):65-76. PubMed ID: 23267129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-Elemene promotes cisplatin-induced cell death in human bladder cancer and other carcinomas.
    Li QQ; Wang G; Liang H; Li JM; Huang F; Agarwal PK; Zhong Y; Reed E
    Anticancer Res; 2013 Apr; 33(4):1421-8. PubMed ID: 23564782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-elemene effectively suppresses the growth and survival of both platinum-sensitive and -resistant ovarian tumor cells.
    Lee RX; Li QQ; Reed E
    Anticancer Res; 2012 Aug; 32(8):3103-13. PubMed ID: 22843880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitization of lung cancer cells to cisplatin by β-elemene is mediated through blockade of cell cycle progression: antitumor efficacies of β-elemene and its synthetic analogs.
    Li QQ; Wang G; Huang F; Li JM; Cuff CF; Reed E
    Med Oncol; 2013 Mar; 30(1):488. PubMed ID: 23397083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-Elemene against human lung cancer via up-regulation of P53 protein expression to promote the release of exosome.
    Li J; JunYu ; Liu A; Wang Y
    Lung Cancer; 2014 Nov; 86(2):144-50. PubMed ID: 25204604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of cisplatin-induced apoptosis by β-elemene in resistant human ovarian cancer cells.
    Li QQ; Lee RX; Liang H; Zhong Y; Reed E
    Med Oncol; 2013 Mar; 30(1):424. PubMed ID: 23277286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cisplatin in combination with β-elemene as a regimen for prostate cancer chemotherapy.
    Li QQ; Wang G; Reed E; Huang L; Cuff CF
    Basic Clin Pharmacol Toxicol; 2010 Nov; 107(5):868-76. PubMed ID: 22545969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1.
    Chen X; Wang Y; Luo H; Luo Z; Zhang T; Yang N; Long X; Xie H; Qiu W; Zhang B; Ding J; Yang L
    Mol Med Rep; 2012 Nov; 6(5):989-95. PubMed ID: 22895653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-Elemene, a novel plant-derived antineoplastic agent, increases cisplatin chemosensitivity of lung tumor cells by triggering apoptosis.
    Li QQ; Wang G; Zhang M; Cuff CF; Huang L; Reed E
    Oncol Rep; 2009 Jul; 22(1):161-70. PubMed ID: 19513519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-elemene induces caspase-dependent apoptosis in human glioma cells in vitro through the upregulation of Bax and Fas/ FasL and downregulation of Bcl-2.
    Li CL; Chang L; Guo L; Zhao D; Liu HB; Wang QS; Zhang P; Du WZ; Liu X; Zhang HT; Liu Y; Zhang Y; Xie JH; Ming JG; Cui YQ; Sun Y; Zhang ZR; Jiang CL
    Asian Pac J Cancer Prev; 2014; 15(23):10407-12. PubMed ID: 25556484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-Elemene and taxanes synergistically induce cytotoxicity and inhibit proliferation in ovarian cancer and other tumor cells.
    Zou B; Li QQ; Zhao J; Li JM; Cuff CF; Reed E
    Anticancer Res; 2013 Mar; 33(3):929-40. PubMed ID: 23482764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Elemene Triggers ROS-dependent Apoptosis in Glioblastoma Cells Through Suppressing STAT3 Signaling Pathway.
    Cai SZ; Xiong QW; Zhao LN; Ji YT; Luo ZX; Ma ZR
    Pathol Oncol Res; 2021; 27():594299. PubMed ID: 34257541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Elemene enhances the efficacy of gefitinib on glioblastoma multiforme cells through the inhibition of the EGFR signaling pathway.
    Mu L; Wang T; Chen Y; Tang X; Yuan Y; Zhao Y
    Int J Oncol; 2016 Oct; 49(4):1427-36. PubMed ID: 27498706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local Delivery of β-Elemene Improves Locomotor Functional Recovery by Alleviating Endoplasmic Reticulum Stress and Reducing Neuronal Apoptosis in Rats with Spinal Cord Injury.
    Wang J; Li H; Ren Y; Yao Y; Hu J; Zheng M; Ding Y; Chen YY; Shen Y; Wang LL; Zhu Y
    Cell Physiol Biochem; 2018; 49(2):595-609. PubMed ID: 30165357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of beta-elemene in non-small-cell lung cancer cells is mediated via induction of cell cycle arrest and apoptotic cell death.
    Wang G; Li X; Huang F; Zhao J; Ding H; Cunningham C; Coad JE; Flynn DC; Reed E; Li QQ
    Cell Mol Life Sci; 2005 Apr; 62(7-8):881-93. PubMed ID: 15868411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. β-elemene against Burkitt's lymphoma via activation of PUMA mediated apoptotic pathway.
    Hu T; Gao Y
    Biomed Pharmacother; 2018 Oct; 106():1557-1562. PubMed ID: 30119230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro combination characterization of the new anticancer plant drug beta-elemene with taxanes against human lung carcinoma.
    Zhao J; Li QQ; Zou B; Wang G; Li X; Kim JE; Cuff CF; Huang L; Reed E; Gardner K
    Int J Oncol; 2007 Aug; 31(2):241-52. PubMed ID: 17611679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. β-Elemene inhibits proliferation through crosstalk between glia maturation factor β and extracellular signal‑regulated kinase 1/2 and impairs drug resistance to temozolomide in glioblastoma cells.
    Zhu TZ; Li XM; Luo LH; Xu YH; Cao P; Liu Y; Liang GB
    Mol Med Rep; 2014 Aug; 10(2):1122-8. PubMed ID: 24866280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT.
    Liang Y; Li S; Zheng G; Zhang L
    Acta Histochem; 2020 May; 122(4):151538. PubMed ID: 32183989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Elemene enhances susceptibility to cisplatin in resistant ovarian carcinoma cells via downregulation of ERCC-1 and XIAP and inactivation of JNK.
    Li QQ; Lee RX; Liang H; Wang G; Li JM; Zhong Y; Reed E
    Int J Oncol; 2013 Sep; 43(3):721-8. PubMed ID: 23817665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.